S. Bowlin

发表

Intermittent claudication in 8343 men and 21-year specific mortality follow-up.

S. Flocke, J. Medalie, U. Goldbourt, 1997, Annals of epidemiology.

Reliability and changes in validity of self-reported cardiovascular disease risk factors using dual response: the behavioral risk factor survey.

S. Bowlin, A. Nafziger, B. D. Morrill, 1996, Journal of clinical epidemiology.

Validity of cardiovascular disease risk factors assessed by telephone survey: the Behavioral Risk Factor Survey.

S. Bowlin, P. Jenkins, A. Nafziger, 1993, Journal of clinical epidemiology.

Coronary bypass in vascular patients: A relatively high-risk procedure

A. Geha, S. Bowlin, L. Graham, 1997, Annals of vascular surgery.

Design and Details of a Prospective Global Short Bowel Syndrome Patient Population Registry: 1765

S. Bowlin, N. Youssef, Eric H. Kim, 2015 .

Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States.

S. Bowlin, C. Koro, B. H. Lee, 2009, Clinical therapeutics.

Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indication

S. Weiss, S. Bowlin, C. Koro, 2005, Pharmacoepidemiology and drug safety.

Comparison of corneal endothelial image analysis by Konan SP8000 noncontact and Bio-Optics Bambi systems.

R. Laing, S. Bowlin, S. S. Oak, 1999, Cornea.

Longitudinal changes in dehydroepiandrosterone concentrations in men and women.

S. Bowlin, P. Jenkins, A. Nafziger, 1998, The Journal of laboratory and clinical medicine.

The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.

G. Nichols, D. Sprecher, S. Bowlin, 2006, Clinical therapeutics.

A decade of postmenopausal hormone therapy prescribing in the United States: long-term effects of the Women’s Health Initiative

S. Bowlin, William Chen, Amy R. Steinkellner, 2012, Menopause.

Epidemiology of intermittent claudication in middle-aged men.

S. Flocke, J. Medalie, U. Goldbourt, 1994, American journal of epidemiology.

Overall benefit of antiretroviral treatment on the risk of fracture in HIV: nested case–control analysis in a health-insured population

A. Youk, G. McComsey, S. Bowlin, 2012, AIDS.

Breast cancer risk and alcohol consumption: results from a large case-control study.

M. C. Leske, P. Nasca, L. Caplan, 1997, International journal of epidemiology.

Silicone Gel Breast Implant Rupture Rates: Research Issues

L. Perkins, S. Bowlin, S. Hoshaw, 2002, Annals of plastic surgery.

Screening for hypercholesterolemia.

T. Pearson, S. Bowlin, W. Sigmund, 1990, Annual review of medicine.

Antisilicone Antibodies in Patients with Silicone Implants for Retinal Detachment Surgery

S. Bowlin, S. Hoshaw, P. Klykken, 2002, Ophthalmic Research.

Atrial fibrillation as a risk factor for stroke: a retrospective cohort study of hospitalized Medicare beneficiaries.

D. Einstadter, R. Cebul, Z. Yuan, 1998, American journal of public health.

Use of antibiotics in preventing recurrent acute otitis media and in treating otitis media with effusion. A meta-analytic attempt to resolve the brouhaha.

K C Stange, K. Stange, T. Chalmers, 1993, JAMA.

Risk of Myocardial Infarction and Abacavir Therapy: No Increased Risk Across 52 GlaxoSmithKline-Sponsored Clinical Trials in Adult Subjects

D. Lapierre, L. Curtis, S. Bowlin, 2009, Journal of acquired immune deficiency syndromes.

A large pharmacy claims-based descriptive analysis of patients with migraine and associated pharmacologic treatment patterns

D. Muzina, S. Bowlin, William Chen, 2011, Neuropsychiatric disease and treatment.

The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary events.

W. Tierney, T. Stump, D. Sprecher, 2006, American heart journal.

An ecological study of the effectiveness of mammography in reducing breast cancer mortality.

L. Dennis, A. Rimm, H. Chen, 1998, American journal of public health.

Ethnic Disparities and Trends in Glycemic Control Among Adults With Type 2 Diabetes in the U.S. From 1988 to 2002 A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

Tao Fan, T. Fan, S. Bowlin, 2006, Diabetes Care.

Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations.

J. Foody, S. Bowlin, William Chen, 2011, The American journal of cardiology.

Cardiovascular disease risk among subjects with impaired fasting glucose in the United States: Results from NHANES 1999–2004

S. Bowlin, C. Koro, D. Fedder, 2008 .

Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report.

S. Bowlin, C. Koro, Carol E Koro, 2004, Diabetes care.

Twelve-month frequency of drug-metabolizing enzyme and transporter-based drug-drug interaction potential in patients receiving oral enzyme-targeted kinase inhibitor antineoplastic agents.

E. Stanek, S. Bowlin, Keisha Robinson, 2013, Mayo Clinic proceedings.

Assessment of risk in longitudinal observational studieswith time-varying drug exposures for treatment of achronic disease

A. Youk, S. Bowlin, L. Mundy, 2015 .

Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States.

S. Bowlin, C. Koro, B. H. Lee, 2009, Clinical therapeutics.

Silicone gel breast implants.

S. Bowlin, 2001, The Journal of rheumatology.